Decreased PERP expression on peripheral blood mononuclear cells from patient with rheumatoid arthritis negatively

Yanchun Du1, Lin Deng, Yan Li

  • 1The First Hospital of Xiamen University, Xiamen 361003, China.

Abstract

Insights

PERP expression is decreased in rheumatoid arthritis (RA) patients, while IL-17 is increased. PERP may be a therapeutic target for RA by regulating IL-17.

Area of Science:

  • Immunology
  • Molecular Biology
  • Rheumatology

Background:

  • PERP (p53 apoptosis effector) plays a role in p53-mediated apoptosis.
  • Its function in peripheral blood mononuclear cells (PBMCs) of rheumatoid arthritis (RA) patients is not well understood.

Purpose of the Study:

  • To investigate PERP expression levels in PBMCs from RA patients and healthy controls.
  • To analyze the role of PERP in RA pathogenesis, particularly its relationship with IL-17 and disease activity.

Main Methods:

  • Real-time PCR was used to measure mRNA expression of PERP and IL-17 in PBMCs.
  • Correlations between PERP levels, IL-17, and clinical disease parameters (DAS28, RF, CRP, ESR, Anti-CCP, ANA) were analyzed.

Main Results:

  • PERP mRNA levels were significantly decreased in RA patients compared to healthy controls.
  • IL-17 mRNA levels were significantly increased in RA patients.
  • PERP expression negatively correlated with IL-17, DAS28, RF, CRP, and ESR.

Conclusions:

  • PERP expression is altered in RA PBMCs.
  • PERP may contribute to RA pathogenesis by influencing IL-17 levels.
  • PERP represents a potential therapeutic target for RA.

Related Concept Videos

T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...